Visit to the Senate guarantees investments for the Mário Penna Institute
Instituto Mário Penna is very proud of its partners and, as a Philanthropic Institution, it establishes fundamental cooperation with the Government to offer the best treatment to patients and achieve structural and technological improvements.
Yesterday in Brasília, the CEO of Instituto Mário Penna, Marco Antônio Viana Leite, received confirmation of investments via parliamentary amendments. The amount of R$4 million was confirmed in a visit to the President of the Congress, Senator Rodrigo Pacheco and by Senator Alexandre da Silveira.
In conversation with the parliamentarians, the manager presented the strategic recovery plan that has been executed since he took over the entity in 2019, overcoming major challenges and overcomes in this trajectory. The performance has been strongly based on the institutional strategic objectives in force, which are focused on assistance and economic-financial recovery, on the increase in production and hospital revenue, and on the renegotiation of outstanding debts – bank and with suppliers.
The senators showed recognition for the work Mário Penna, which completed 50 years in June 2021, being a true heritage of Minas Gerais and a reference in cancer care in the state. They were promptly sensitized to the demands presented for renovations and investment in new equipment. “Count on me and Senator Rodrigo Pacheco. The funding is being released to reinforce the service, especially for SUS users throughout the state who are served in Mário Penna”, said Senator Alexandre da Silveira, promising to return the visit soon, to closely monitor the application of resources.









Classified by the Ministry of Health as a High Complexity Oncology Care Center (CACON), in 2020 the Institute also carried out 272 thousand radiotherapy applications, 34 thousand chemotherapy sessions, 55 bone marrow transplants and almost 11 thousand surgeries. In addition, it is at the forefront in the fight against Covid-19 and, for this, infirmary beds and other new ICU beds were created, aimed at treating patients with the disease.
According to Dr. Ellias Lima, oncologist and Coordinator of COREME, the objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge. The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place once a month, with educational support from the pharmaceutical industry.
When our cells are going to multiply, whether to repair damaged tissue or to replace other cells, this genetic code needs to duplicate itself. This is important so that each new cell has the same genetic information as the one that originated it. During this duplication step, small errors can happen in the genetic code and they are called mutations.